Jason Casey
Nurse Practitioner · Snellville, GANPI 1003291378
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Johnson & Johnson at 40.4% of the total. Among nurse practitioner clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $93.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$6K
- Medtronic$4K
- Boston Scientific$904
- Antares Pharma, Inc.$409
- Astellas Pharma US Inc$330
- Teleflex LLC$311
- plus $3K from 25 others
What the payments were for
- Consulting fees$4,59032%
- Travel & lodging$3,11722%
- Food & beverage$6,45145%
- Education$2462%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 16 | $5,819 |
| Medtronic | 37 | $3,785 |
| Boston Scientific | 14 | $904 |
| Antares Pharma, Inc. | 6 | $409 |
| Astellas Pharma US Inc | 10 | $330 |
| Teleflex LLC | 8 | $311 |
| Calyxo, Inc. | 3 | $307 |
| Olympus America Inc. | 3 | $285 |
| Procept Biorobotics Corporation | 3 | $285 |
| 180 Medical, Inc. | 9 | $268 |
| Coloplast | 2 | $190 |
| Sumitomo Pharma America, Inc. | 4 | $185 |
| Ferring Pharmaceuticals Inc. | 1 | $138 |
| Endo Pharmaceuticals Inc. | 2 | $137 |
| Inspire Medical Systems, Inc. | 1 | $134 |
| Progenics Pharmaceuticals, Inc. | 6 | $127 |
| Convatec Inc. | 5 | $105 |
| Exact Sciences | 1 | $89 |
| Cequr Corporation | 1 | $84 |
| Photocure Inc | 2 | $78 |
| Tolmar, Inc. | 3 | $68 |
| Urogen Pharma, Inc. | 2 | $58 |
| Azurity Pharmaceuticals, Inc. | 3 | $55 |
| AbbVie | 3 | $51 |
| Endo USA, Inc. | 2 | $51 |
| Verity Pharmaceuticals Inc. | 2 | $46 |
| Axonics, Inc. | 1 | $31 |
| Pfizer | 1 | $24 |
| Merck | 1 | $24 |
| Laborie Medical Technologies Corp. | 1 | $15 |
| Dentsply IH Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monarch Platform$5,204
- INTERSTIM$2,792
- AMS 700$391
- CVAC Aspiration System$300
- iTIND System$247
- TLANDO$247
- AquaBeam Robotic System$246
- XYOSTED$237
- Luja Coude$176
- Moses 550 DFL$140
- ADSTILADRIN$138
- Inspire$134
- ALTAVIVA$129
- XTANDI$125
- XIAFLEX$125
- AMS 700 CXR RTE KIT$123
- GEMTESA$123
- NOCDURNA$122
- UroLift$118
How this compares
$14,404 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 162 | $173,221 |
| GemtesaVibegron | 15 | $12,773 |
| Testosterone | 64 | $6,254 |
| Tamsulosin Hcl | 343 | $4,929 |
| Solifenacin Succinate | 73 | $3,554 |
| Testosterone Cypionate | 73 | $2,621 |
| Potassium Citrate ErPotassium Citrate | 33 | $2,340 |
| Methenamine Hippurate | 16 | $1,828 |
| Trospium Chloride ErTrospium Chloride | 12 | $1,456 |
| Finasteride | 106 | $1,332 |
| Trospium Chloride | 20 | $1,282 |
| Darifenacin ErDarifenacin Hydrobromide | 11 | $1,112 |
| Oxybutynin Chloride ErOxybutynin Chloride | 52 | $1,051 |
| Silodosin | 16 | $1,033 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 39 | $723 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $330 | $173,221162 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $185 | $12,77315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Snellville
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Tajuana BradleyJohns Creek$256K
- Jessica AdkinsSavannah$226K
- Janice McAlisterAtlanta$221K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
- Luis PoloSavannah$70K
- Karen BauerDecatur$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.